What stands out for senior leaders
We selected Nanosonics Limited for a mission that connects infection prevention with patient, clinic, staff and environmental safety. Its focus on introducing innovative technologies to raise standards of care gives senior leaders a clear purpose against which to assess the business.
Nanosonics combines a Sydney base with offices across Australia, the United States, Europe and Japan. Its ASX listing and A$203.9M in FY2026 revenue make it worth considering for leaders drawn to an established health technology business with an international footprint.
Led by CEO Michael Kavanagh, Nanosonics brings together a safety-focused mission and the scale of a publicly listed company. In our judgement, the leadership appeal lies in that combination: technology with a defined clinical purpose, international reach and meaningful commercial scale.
Leadership areas
- Engineering & Technology
- Commercial & Sales
- Operations & Strategy
The honest trade-off
Nanosonics may be less suited to leaders who prefer a privately held business over a publicly listed company. Those seeking a business centred on a single local market may find its international footprint less aligned with their preferences.
Questions leaders ask about Nanosonics Limited
- Who leads Nanosonics Limited, and where is it based?
- Nanosonics is led by CEO Michael Kavanagh and is based in Sydney, Australia. Its offices include Sydney, Indianapolis, Stockport, Dublin, Gif-sur-Yvette, Hamburg and Tokyo.
- Is Nanosonics publicly listed, and what is its revenue?
- Nanosonics is publicly listed on the ASX under NAN. Its FY2026 revenue was A$203.9M.
- What is Nanosonics' mission?
- Its mission is to improve patient, clinic, staff and environmental safety by transforming infection prevention practices and introducing innovative technologies that raise standards of care.
Sources
- nanosonics.com
- Official global office directory
- Official company history and mission
- Official leadership team
- Nanosonics 2026 Annual Report, reproduced by FinancialFilings
- Market capitalisation as at 6 November 2026, sourced from S&P Global Market Intelligence
- Official annual reports and financial results directory
Last checked November 2026











